Discovery and Structure−Activity Relationships of Imidazole-Containing Tetrahydrobenzodiazepine Inhibitors of Farnesyltransferase
Authors:
- 30 October 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (25) , 5241-5253
Abstract
2,3,4,5-Tetrahydro-1-(imidazol-4-ylalkyl)-1,4-benzodiazepines were found to be potent inhibitors of farnesyltransferase (FT). A hydrophobic substituent at the 4-position of the benzodiazepine, linked via a hydrogen bond acceptor, was important to enzyme inhibitory activity. An aryl ring at position 7 or a hydrophobic group linked to the 8-position through an amide, carbamate, or urea linkage was also important for potent inhibition. 2,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-7-(4-pyridinyl)-4-[2-(trifluoromethoxy)benzoyl]-1H-1,4-benzodiazepine (36), with an FT IC50 value of 24 nM, produced 85% phenotypic reversion of Ras transformed NIH 3T3 cells at 1.25 μM and had an EC50 of 160 nM for inhibition of anchorage-independent growth in soft agar of H-Ras transformed Rat-1 cells. Selected analogues demonstrated ip antitumor activity against an ip Rat-1 tumor in mice.Keywords
This publication has 8 references indexed in Scilit:
- Potent, non-thiol inhibitors of farnesyltransferaseBioorganic & Medicinal Chemistry Letters, 1998
- Non-Ras targets of farnesyltransferase inhibitors: focus on RhoOncogene, 1998
- Development of Highly Potent Inhibitors of Ras Farnesyltransferase Possessing Cellular andin VivoActivityJournal of Medicinal Chemistry, 1996
- Review Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapyExpert Opinion on Therapeutic Patents, 1995
- Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferaseDrug Development Research, 1995
- Benzodiazepine peptidomimetic inhibitors of farnesyltransferaseBioorganic & Medicinal Chemistry, 1994
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988
- Synthese von 2‐(2‐Aminoethyl)‐4‐hydroxymethyl‐imidazol+ Synthesis of 2‐(2‐Aminoethyl)‐4‐(hydroxymethyl)imidazoleArchiv der Pharmazie, 1982